alexa
Reach Us +44-1235-425476
Strategic Partnership For Biologics RD | 70768
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Strategic partnership for biologics RD

8th Asian Biologics and Biosimilars Congress

Jianguo Yang

Abpro, USA

Keynote: J Bioanal Biomed

DOI: 10.4172/1948-593X-C1-031

Abstract
Biologic drugs on the market now have been results of some partnership from RD to commercialization. Increasing complexity of biologic drug development requires more collaborations or partnerships in biopharma industry. This presentation will review current status of biologic drugs market and articulate landscape and importance of strategic partnerships in biologic research and development, and future trends.
Biography

Jianguo Yang has obtained his PhD in Cell/Molecular Biology from Illinois Institute of Technology, USA. He has over 20-years extensive experience in biopharma industry. Currently, he is the President/CEO Abpro, China. Before joining Abpro, he was CSO/VP Biologics in Qilu Pharmaceuticals and also had scientific leadership positions in several global pharmaceutical companies, including in Abbott Lab Pharma Division (current AbbVie), MedImmune/AstraZeneca, Genzyme/ Sanofi. He has published numerous patents and scientific papers and is an Editor Advisor and Reviewer for Bioprocess International journal, Executive Director of Sino-America Pharmaceutical Association-NE (2012-2014) and Reviewer for several scientific journals.

Email: [email protected]

Top